CC BY-NC-ND 4.0 · SynOpen 2022; 06(01): 75-79
DOI: 10.1055/s-0040-1719914
spotlight

Tethered Rh(III)-N-(p-Tolylsulfonyl)-1,2-Diphenylethylene-1,2-Diamine Complexes: Efficient Catalysts for Asymmetric Transfer Hydrogenation

Pierre-Georges Echeverria
,
Long-Sheng Zheng
,
Quentin Llopis
,
Bin He
,
Anne Westermeyer
,
Ricardo Molina Betancourt
,
Phannarath Phansavath
,
 


Abstract


#
Zoom Image
Phannarath Phansavathreceived her PhD from Pierre & Marie Curie University (Paris, France) in 1997 under the supervision of Prof. M. Malacria and Dr. C. Aubert. After postdoctoral studies in the group of Prof. C. Bolm at the Institut für Organische Chemie, RWTH Aachen (Germany), she was appointed assistant professor in 1999 in the group of Prof. J.-P. Genêt at ENSCP. Her current research interests at Chimie ParisTech include total synthesis of biologically relevant natural products and transition-metal-catalyzed asymmetric reactions. Virginie Vidal completed her PhD at Paris-Sud University under the supervision of Prof. H. P. Husson and Dr. J. Royer (Gif, France) and was a FRM postdoctoral fellow at the University of Montreal with Prof. S. Hanessian­ (Canada, 1989–1990), and in 1991 with Prof. P. Potier and Dr. R. H. Dodd (Gif). She was appointed as a CNRS Associate Researcher with Prof. J. P. Genêt at ENSCP. She is currently CNRS Research Director at Chimie ParisTech (Paris, France). Her research interests focus on the development of transition-metal catalysis and the design of atropisomeric ligands (Synphos and Difluorphos). The synthesis of biorelevant targets is also a focus in her research group.

Transition-metal-catalyzed asymmetric transfer hydrogenation (ATH)[1] of prochiral ketones is an efficient method to access enantiomerically pure secondary alcohols that are key intermediates in the pharmaceutical industry and for the manufacture of advanced materials. For this reaction, Noyori developed a Ru(II) complex having a N-(p-toluenesulfonyl)-1,2-diphenylethylendiamine (TsDPEN) ligand that was used with either isopropanol or formate salts as the hydrogen donor.[2] Related Rh(III)-TsDPEN and Ir(III)-TsDPEN catalysts as well as modified Ru(II) and Rh(III) complexes have also been reported. In particular, Wills disclosed the Rh-tethered complex (R,R)-A [3] containing a tethering group between the diamino group and the cyclopentadienyl unit providing extra stereochemical stability and hence higher selectivities (Scheme [1]). To investigate the influence of the R substituent of the 2-benzyl tether, our group developed a series of tethered rhodium complexes (R,R)-B–(R,R)-E having electron-donating (methoxy and methyl) as well as electron-withdrawing (fluorine and trifluoromethyl) substituents, respectively, on the 2-benzyl tether.[4] The N-pentafluorophenylsulfonyl-DPEN-based tethered Rh(III) complex (R,R)-F [5] was also synthesized.

Zoom Image
Scheme 1 Synthesis of complexes BF and X-ray crystallographic structures of BD, F

Complexes (R,R)-B–(R,R)-F were prepared according to the route disclosed for the parent complex (R,R)-A [3] [6] (Scheme [1]). After acetal protection of the required 5-substituted 2-bromo-benzaldehyde derivatives 1 to provide compounds 2, treatment of the latter with n-BuLi followed by addition of 2,3,4,5-tetramethylcyclopent-2-enone afforded the corresponding alcohols that under acidic treatment underwent concomitant deprotection of the aldehyde and dehydration of the tertiary alcohol to give the cyclopentadiene derivatives 3. Subsequent reductive amination of the latter using (R,R)-TsDPEN or (R,R)-FsDPEN followed by treatment with RhCl3 led to (R,R)-B–(R,R)-F as single diastereomers.

Complexes (R,R)-B–(R,R)-E exhibited excellent activities for the ATH of a wide range of functionalized ketones 4 [4] using the formic acid/triethylamine (5:2) system as the hydrogen source, giving the corresponding alcohols 5 with selectivities comparable to those obtained with Wills’ complex (R,R)-A [3] or slightly higher in some instances, and with a better catalytic activity observed in several cases (Table [1], A).

Table 1 Applications of Complexes (R,R)-A–(R,R)-F

(A) ATH of Functionalized Ketones [3] [4]

- Access to secondary alcohols under mild conditions

- Low catalyst loading

- High enantioselectivities

- Broad substrate scope

(B) ATH/DKR of Aromatic α-Amino β-Keto Ester Hydrochlorides [7]

- Access to anti-α-amino-β-hydroxy ester derivatives

- Fair diastereoselectivities

- High to excellent enantioinductions

- Access to syn-α-amino-β-hydroxy ester derivatives with heteroaromatic compounds

(C) ATH/DKR of α-Benzoylamido β-Keto Esters [9]

- Preparation of syn-α-benzoylamido-β-hydroxy esters

- Low catalyst loading

- 2 stereogenic centers controlled in a single step

- Excellent enantioselectivities

(D) ATH/DKR of α-Methoxy-β-keto Esters [5]

- Synthesis of anti-α-methoxy-β-hydroxy esters

- Use of environmentally sound solvents

- Low catalyst loading

- Control of 2 stereocenters in a single step

- Excellent diastereo- and enantioselectivities

(E) ATH/DKR of 3-Substituted Chromones [10]

- Preparation of cis-3-hydroxymethyl chroman-4-ol derivatives

- Multiple reductions of C=O and C=C bonds with one catalyst

- New catalytic ATH cascade sequence

- Applicability of the method for large scale reactions

- 2 stereogenic centers controlled in a single step

- Excellent diastereo- and enantioselectivities

(F) ATH of β-keto-γ-acetal enamides [11]

- Access to β-hydroxy-γ-acetal enamides

- Mild conditions

- Low catalyst loading

- Excellent chemo- and enantioselectivities

(G) ATH of Quinolone Derivatives [12]

- Efficient and practical access to 1,2,3,4-tetrahydroquinolin-4-ols

- Catalytic ATH cascade reaction

- Mild conditions

- Excellent enantiofacial discrimination

(H) ATH/DKR of 3-Benzylidene Chromanones [13]

- One-pot ATH cascade protocol to access cis-benzyl-chromanols

- Low catalyst loading

- 2 stereogenic centers controlled in a single step

- Excellent diastereo- and enantioselectivities

(I) ATH/KR of 2-Aryl-2,3-dihydroquinolin-4(1H)-ones [14]

- Synthesis of 2-aryl-2,3-dihydroquinolin-4(1H)-ones and 2-aryl tetrahydro-4-quinolols

- Efficient kinetic resolution

- Excellent enantioselectivities

(J) ATH of α-Aminoalkyl α′-Chloromethyl Ketones [15]

- Access to both diastereomers of 3-amino-1-chloro-2-hydroxy-4-phenylbutanes

- Low catalyst loading

- Excellent yields and high diastereoselectivities

- Key building blocks for pharmaceutical intermediates

- Broad scope

(K) ATH/DKR of α-Substituted β-Keto Carbonitriles [16]

- Efficient access to α-substituted β-hydroxy carbonitriles

- Building blocks for biologically active pharmaceuticals

- Excellent yields

- High diastereoselectivities and excellent enantioselectivities

- Rationalization of the diastereoselectivity by DFT calculations

- Wide substrate scope

In particular, complex (R,R)-B having the electron-donating methoxy substituent on the 2-benzyl tether exhibited the highest catalytic performance and was used afterwards for further ATH studies. Aromatic α-amino β-keto ester hydrochlorides 6 underwent ATH-induced by Rh complex (R,R)-B with good yields, fair diastereoselection, and excellent enantioselectivities[7] through a dynamic kinetic resolution (DKR) process.[8] The corresponding anti-amino alcohols 7 were obtained after N-benzoylation; whereas the syn compounds 8 were formed starting from heteroaromatic ketones 6 (Table [1], B).[7] On the other hand, an access to syn-α-benzoylamido-β-hydroxy esters 10 was developed through ATH/DKR of α-benzoylamido β-keto esters 9 with high yields (up to 98%) and diastereomeric ratios (up to >99:1 dr) as well as excellent enantioselectivities (up to >99% ee, Table [1], C).[9] The asymmetric reduction of α-methoxy β-keto esters 11 through transfer hydrogenation using rhodium(III) complexes (R,R)-B and (R,R)-F, respectively, was performed in 2-MeTHF with formic acid/triethylamine or in water with sodium formate in the presence of cetyltrimethylammonium bromide (CTAB) as a surfactant. The corresponding syn-α-methoxy-β-hydroxy esters 12 were obtained with high diastereoselectivities and excellent levels of enantioselectivity via a DKR process under environmentally sustainable conditions (Table [1], D).[5] Enantioenriched cis-3-hydroxymethyl chroman-4-ol derivatives 14 were conveniently prepared by ATH/DKR of 3-formyl chromones 13 using complex (R,R)-B and HCO2H/Et3N (5:2) as the hydrogen source, delivering the reduced compounds in diastereomeric ratios up to 98:2 and enantioselectivities up to >99% ee through a new catalytic ATH cascade sequence that provided multiple reductions of C=O and C=C bonds with one catalyst (Table [1], E).[10] The ATH of β-keto-γ-acetal enamides 15 has been studied with complex (R,R)-B and the HCO2H/Et3N (5:2) azeotropic mixture delivering a wide range of enantioenriched β-hydroxy-γ-acetal enamides 16 with a high chemoselectivity observed toward the reduction of the carbonyl group over the C=C bond, yields up to quantitative and enantioselectivities up to 99% (Table [1], F).[11] The same catalytic system was used to access 1,2,3,4-tetrahydroquinolin-4-ols 18 conveniently through ATH of 4-quinolone derivatives 17 with excellent enantioselectivities under mild conditions (Table [1], G).[12] A straightforward access to enantiomerically enriched cis-3-benzylchromanols 20 was developed through ATH of (E)-3-benzylidene-chromanones 19 using complex (R,R)-B. This one-pot ATH cascade protocol allowed the reduction of the C=C and C=O bonds and the formation of two stereocenters in high yields with diastereo- and enantioselectivities up to >99:1 dr and >99% ee through a DKR process using a low catalyst loading and HCO2H/DABCO as the hydrogen source (Table [1], H).[13] The kinetic resolution (KR) of 2-aryl tetrahydro-4-quinolone derivatives 21 was efficiently achieved through ATH using the previous catalytic system. The reaction afforded the enantiomerically enriched 2-aryl-2,3-dihydroquinolin-4(1H)-ones 23 with excellent levels of enantioselectivity (up to >99% ee) as well as the corresponding synthetically useful enantiomerically enriched 2-aryl tetrahydro-4-quinolols 22 in high isolated yields and up to >99% enantioselectivity (Table [1], I).[14] The ATH of α-aminoalkyl α′-chloromethyl ketones 24 using (R,R)-B or (S,S)-B afforded a series of chiral 3-amino-1-chloro-2-hydroxy-4-phenylbutanes 25 or 26 in excellent yields and diastereoselectivities, with both diastereomers of the reduced products available (up to 99% yield, up to 99:1 dr, Table [1], J).[15] α-Substituted β-keto carbonitriles 27 and 28 were efficiently reduced with (R,R)-B and HCO2H/Et3N (5:2) to the corresponding α-substituted β-hydroxy carbonitriles 29 and 30 in excellent enantio- and diastereoselectivities (up to >99% ee, up to >99:1 dr) through a DKR process offering rapid access to key intermediates of biologically active pharmaceuticals (Table [1], K).[16]

Rh-tethered complexes (R,R)-B–(R,R)-E have been developed and used in the ATH of a wide range of functionalized ketones exhibiting excellent activities and selectivities. Among them, complex (R,R)-B was particularly efficient to produce a series of enantioenriched alcohols including oxygen- and nitrogen-containing heterocycles such as cis 3-hydroxymethyl chroman-4-ols, cis-3-benzyl-chromanols, 1,2,3,4-tetrahydroquinolin-4-ols, and 2-aryl tetrahydro-4-quinolol derivatives as well as carbocycles such as α-substituted β-hydroxy carbonitriles. Additional examples of catalytic applications involved the preparation of syn-α-benzoylamido and α-methoxy β-hydroxy esters, 3-amino-1-chloro-2-hydroxy-4-phenylbutanes, and β-hydroxy-γ-acetal enamides. The selective transformations promoted by the Rh(III) catalysts, developed in our group, proceeded under mild conditions at low catalyst loading, and can occur in a one-pot fashion through ATH cascade reactions that demonstrated the practical applicability of these promising complexes for future applications.


#

Conflict of Interest

The authors declare no conflict of interest.


Corresponding Authors

Phannarath Phansavath
PSL University, Chimie ParisTech, CNRS, UMR 8060, Institute of Chemistry for Life and Health Sciences, CSB2D Team
75005 Paris
France   
Virginie Ratovelomanana-Vidal
PSL University, Chimie ParisTech, CNRS, UMR 8060, Institute of Chemistry for Life and Health Sciences, CSB2D Team
75005 Paris
France   

Publication History

Received: 18 February 2022

Accepted after revision: 04 March 2022

Article published online:
24 March 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany


Zoom Image
Phannarath Phansavathreceived her PhD from Pierre & Marie Curie University (Paris, France) in 1997 under the supervision of Prof. M. Malacria and Dr. C. Aubert. After postdoctoral studies in the group of Prof. C. Bolm at the Institut für Organische Chemie, RWTH Aachen (Germany), she was appointed assistant professor in 1999 in the group of Prof. J.-P. Genêt at ENSCP. Her current research interests at Chimie ParisTech include total synthesis of biologically relevant natural products and transition-metal-catalyzed asymmetric reactions. Virginie Vidal completed her PhD at Paris-Sud University under the supervision of Prof. H. P. Husson and Dr. J. Royer (Gif, France) and was a FRM postdoctoral fellow at the University of Montreal with Prof. S. Hanessian­ (Canada, 1989–1990), and in 1991 with Prof. P. Potier and Dr. R. H. Dodd (Gif). She was appointed as a CNRS Associate Researcher with Prof. J. P. Genêt at ENSCP. She is currently CNRS Research Director at Chimie ParisTech (Paris, France). Her research interests focus on the development of transition-metal catalysis and the design of atropisomeric ligands (Synphos and Difluorphos). The synthesis of biorelevant targets is also a focus in her research group.
Zoom Image
Scheme 1 Synthesis of complexes BF and X-ray crystallographic structures of BD, F